Shares of Unichem Laboratories Ltd jumped over 3% in the afternoon trade after the company received USFDA approval for Kolhapur unit with no observations.
The company’s newly commissioned Active Pharmaceutical Ingredients (APIs) facility at Kolhapur, Maharashtra was inspected by the United States Food and Drug Administration (USFDA) from September 16, 2019, to September 20, 2019, the company said in the filing.
The inspection was cGMP surveillance and pre-approval inspection and was successfully concluded without any FDA form 483 issued, the company added.
Unichem Laboratories Ltd is currently trading at Rs193.55, up by Rs4.55 or 2.41% from its previous closing of Rs189 on the BSE.
The scrip opened at Rs188.85 and has touched a high and low of Rs200.60 and Rs184.20 respectively.
